LEONARD JOHN M — SEC Form 4 filings
SEC reporting owner CIK 1563584. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-05 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 171,774 shares, $1,764,197 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 49,959 shares @ $9.49 ($474,111) in Intellia Therapeutics, Inc., filed 2025-12-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | President and CEO, Director | 8 | — | 7 legs · 171,774 sh · $1,764,197 | 12 |
| IQVIA HOLDINGS INC. (IQV) | Director | 3 | — | — | 3 |
Form 4 filings — LEONARD JOHN M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 19,890 @ $12.60 · Sale (S): 2,785 @ $13 | EDGAR |
| 2026-04-27 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,571 @ $0 | EDGAR |
| 2026-03-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 156,400 @ $0 · Grant/award (A): 225,400 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 34,146 @ $9.21 | EDGAR |
| 2025-12-12 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 49,959 @ $6.83 · Sale (S): 49,959 @ $9.49 · Sale (S): 32,832 @ $9.47 · Sale (S): 5,355 @ $9.59 · Option exercise (M): 8,557 @ $6.83 · Option exercise (M): 49,959 (derivative) @ $0 · +1 more | EDGAR |
| 2025-04-25 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,592 @ $0 | EDGAR |
| 2025-03-04 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 136,000 @ $0 · Grant/award (A): 196,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 26,807 @ $12.18 | EDGAR |
| 2025-01-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 7,850 · Option exercise (M): 7,850 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,047 @ $0 | EDGAR |
| 2024-03-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 113,586 @ $0 · Grant/award (A): 163,929 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1563584 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →